Cancer immunotherapy drugs called PD-1 inhibitors are widely used to stimulate the immune system to fight cancer, but many patients either don't respond or develop resistance to them. A new small-molecule drug candidate being tested in an early-stage clinical trial aims to improve patient responses to immunotherapy.
retrieved 4 October 2023 from https://medicalxpress.com/news/2023-10-cancer-immunotherapy-candidate-provokes-powerful.html
Prostate cancer—a notable killer of Black men—can be made less deadly by modifying key risks, new study finds11 hours ago
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Study identifies a novel regulator of dormant cancer cells and chemoresistance in colorectal cancerMore than 1.9 million new colorectal cancer (including anus) cases and 935,000 deaths were estimated to occur worldwide in 2020, representing about one in 10 cancer cases and deaths. Overall, colorectal ranks third in terms of incidence, but second in terms of mortality. Intrinsic or acquired resistance to chemotherapy leads to disease relapse in many CRC patients, representing and unmet clinical need.
Read more »
Jill Biden urges women to get mammograms or other cancer exams during Breast Cancer Awareness MonthJill Biden is urging women to consult their doctors about getting mammograms or other cancer screenings, saying in a new public service announcement for Breast Cancer Awareness Month that early detection saves lives.
Read more »
New drugs have increased survival rates for men with metastatic prostate cancerSurvival rates for men with metastatic prostate cancer have increased by an average of six months, something which coincides with the gradual introduction of 'dual treatment' since 2016.
Read more »